The IL-17 differentiation pathway and its role in transplant outcome.
about
Current data on IL-17 and Th17 cells and implications for graft versus host disease.Kinetics of IFN-γ and IL-17 Production by CD4 and CD8 T Cells during Acute Graft-versus-Host Disease.Lung parenchyma-derived IL-6 promotes IL-17A-dependent acute lung injury after allogeneic stem cell transplantationAn activated Th17-prone T cell subset involved in chronic graft-versus-host disease sensitive to pharmacological inhibition.The biology of graft-versus-host disease: experimental systems instructing clinical practice.IL-17 genetic and immunophenotypic evaluation in chronic graft-versus-host disease.Small molecule inhibitors of RORγt: targeting Th17 cells and other applications.Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammationCytokines in tear fluid of patients with ocular graft-versus-host disease after allogeneic stem cell transplantation.Proteomic analysis of saliva from patients with oral chronic graft-versus-host diseaseRegulation of pulmonary graft-versus-host disease by IL-26+CD26+CD4 T lymphocytes.Acute graft-versus-host disease is regulated by an IL-17-sensitive microbiome.Th17 mediated alloreactivity is facilitated by the pre-transplant microbial burden of the recipient.IL-1 Receptor Blockade Alleviates Graft-versus-Host Disease through Downregulation of an Interleukin-1β-Dependent Glycolytic Pathway in Th17 CellsOral chronic graft-versus-host disease: current pathogenesis, therapy, and researchEssentials of Th17 cell commitment and plasticityTargeted Rho-associated kinase 2 inhibition suppresses murine and human chronic GVHD through a Stat3-dependent mechanism.Proteomics analysis reveals a Th17-prone cell population in presymptomatic graft-versus-host disease.Autophagy-dependent regulatory T cells are critical for the control of graft-versus-host disease.Genetically engineered donor T cells to optimize graft-versus-tumor effects across MHC barriers.Biology of chronic graft-vs-host disease: Immune mechanisms and progress in biomarker discovery.Pirfenidone ameliorates murine chronic GVHD through inhibition of macrophage infiltration and TGF-β production.Chronic graft-versus-host disease: biological insights from preclinical and clinical studies.Multiplex and genome-wide analyses reveal distinctive properties of KIR+ and CD56+ T cells in human bloodRisk Factors and Outcomes of Invasive Fungal Infections in Allogeneic Hematopoietic Cell Transplant Recipients.Bronchiolitis obliterans syndrome in adults after allogeneic stem cell transplantation-pathophysiology, diagnostics and treatment.Regulation of Interleukin-17 Production.An unexpected role for platelets in blocking Th17 differentiation.Donor Th17 cells and IL-21 may contribute to the development of chronic graft-versus-host disease after allogeneic transplantation.A critical role for donor-derived IL-22 in cutaneous chronic GVHD.Application of proteomics to graft-versus-host disease: from biomarker discovery to potential clinical applications.Cytokine mediators of chronic graft-versus-host disease.Adoptively transferred donor IL-17-producing CD4+ T cells augment, but IL-17 alleviates, acute graft-versus-host disease.Th17 plasticity and transition toward a pathogenic cytokine signature are regulated by cyclosporine after allogeneic SCT
P2860
Q30654527-8BD050A7-9884-465F-810E-97A2095283FDQ33619021-32F06D53-06B2-499E-8677-1A3406122604Q33758318-6AE86956-72D3-4E54-8252-D2B3BBBDA96EQ33798102-043417CE-A7D7-4C66-8586-9FF6335DD5C6Q33917175-FE6001BB-EDA7-4056-AEE3-AAAB0FB59DFEQ34029809-D6E27378-138D-44B2-B8AD-CAEEA1955A63Q34297607-59FBA771-6E33-415B-93F7-5C1F5CC1F862Q35242438-5754F80C-F821-4590-BF5F-F32445DF9E5AQ35883325-4ED2D458-ABD8-4233-98AC-000309B6B276Q36004178-B5D75591-9C81-462B-8B1E-369B01FEB8BEQ36056986-AA9895C7-551D-4B1A-B686-BFA7C554E47BQ36264301-267AF6B3-B1E2-4183-B712-E82359010504Q36321016-8D4FDE85-D0C9-4071-9965-D94DDB20E092Q36423549-432237F5-46A2-43BA-BD01-511EAB274BB2Q36579263-79DF2D86-7F60-40E4-976F-94F22FF4C5A1Q36730400-8C18B0BB-FCED-489B-B705-515B03FBAF70Q36851405-3BE2593D-1DD5-4B6A-9183-F57A7B44410DQ36904560-D365183B-9443-4F50-813A-A03CA9367C71Q37277015-63C4BADA-EA6F-4E06-AA43-075312E46C01Q37416883-53BC4B14-DCCD-42E4-B099-71A038A85FA0Q37522548-D70D6EC3-A7E4-4C12-92D2-90FBBE3F4CC2Q38932342-F47EAC44-C9C1-4668-AA4B-4F2B76B59DB7Q39002164-26F26B0A-8509-4372-A7EF-0835B113E23BQ39125360-36CE6932-41D2-400C-A99E-85F6BF8C4DC4Q40357629-8B1FCA96-4122-47EF-8974-DB452CCC7A92Q40385568-05D7A24F-2AEB-4AC8-9BA7-9BC42E2656D6Q40508654-794FCD60-D181-4124-BB34-21AFB3206D3DQ41833758-840BD9B0-1E6A-4815-AFDD-F93DC1C1C834Q46779685-4366B611-7B4C-4166-A612-5FF93F8C5FFEQ47935463-BFDB2F06-01F4-45E0-BC9C-6E1D844CA888Q49645938-24445474-AD45-40CD-81D1-4E7FB9DD0B9BQ50915048-8FA75238-9D09-469D-BA09-91C54612EB8FQ52880882-82791AC7-888F-4AB6-A925-1E7CB6AD8159Q57252613-BDAC3F87-29F4-4EA0-96C3-CF3F758C0FF0
P2860
The IL-17 differentiation pathway and its role in transplant outcome.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The IL-17 differentiation pathway and its role in transplant outcome.
@en
The IL-17 differentiation pathway and its role in transplant outcome.
@nl
type
label
The IL-17 differentiation pathway and its role in transplant outcome.
@en
The IL-17 differentiation pathway and its role in transplant outcome.
@nl
prefLabel
The IL-17 differentiation pathway and its role in transplant outcome.
@en
The IL-17 differentiation pathway and its role in transplant outcome.
@nl
P2860
P1476
The IL-17 differentiation pathway and its role in transplant outcome.
@en
P2860
P304
P356
10.1016/J.BBMT.2011.10.001
P433
P577
2012-01-01T00:00:00Z